Majerova T, Konvalinka J
Mol Aspects Med. 2022; 88:101159.
PMID: 36459838
PMC: 9706241.
DOI: 10.1016/j.mam.2022.101159.
Mazar J, Rosado A, Shelley J, Marchica J, Westmoreland T
Oncotarget. 2016; 8(4):6589-6607.
PMID: 28035057
PMC: 5351655.
DOI: 10.18632/oncotarget.14244.
Jaskolski M, Miller M, Mohana Rao J, Gustchina A, Wlodawer A
FEBS J. 2015; 282(21):4059-66.
PMID: 26258480
PMC: 6310002.
DOI: 10.1111/febs.13397.
Miller M
Biopolymers. 2010; 94(4):521-9.
PMID: 20593466
PMC: 2938048.
DOI: 10.1002/bip.21387.
Nishiuchi Y, Inui T, Nishio H, Bodi J, Kimura T, Tsuji F
Proc Natl Acad Sci U S A. 1998; 95(23):13549-54.
PMID: 9811837
PMC: 24856.
DOI: 10.1073/pnas.95.23.13549.
Synergistic binding of inhibitors to the protease from HIV type 1.
Asante-Appiah E, Chan W
Biochem J. 1996; 315 ( Pt 1):113-7.
PMID: 8670094
PMC: 1217158.
DOI: 10.1042/bj3150113.
Development of activity assays for high-volume evaluation of human immunodeficiency virus (HIV) protease inhibitors in rat serum: results with ditekiren.
Wilkinson K, Rush B, Sharma S, Evans D, Ruwart M, Friis J
Pharm Res. 1993; 10(4):562-6.
PMID: 8483839
DOI: 10.1023/a:1018950003185.
Large scale purification and refolding of HIV-1 protease from Escherichia coli inclusion bodies.
Hui J, Tomasselli A, Reardon I, Lull J, Brunner D, Tomich C
J Protein Chem. 1993; 12(3):323-7.
PMID: 8397790
DOI: 10.1007/BF01028194.
Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus.
Elder J, Schnolzer M, Henson M, Lerner D, Phillips T, Wagaman P
J Virol. 1993; 67(4):1869-76.
PMID: 8383214
PMC: 240254.
DOI: 10.1128/JVI.67.4.1869-1876.1993.
Design of peptide enzymes (pepzymes): surface-simulation synthetic peptides that mimic the chymotrypsin and trypsin active sites exhibit the activity and specificity of the respective enzyme.
Atassi M, Manshouri T
Proc Natl Acad Sci U S A. 1993; 90(17):8282-6.
PMID: 8367494
PMC: 47333.
DOI: 10.1073/pnas.90.17.8282.
In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease.
Otto M, Garber S, Winslow D, Reid C, ALDRICH P, Jadhav P
Proc Natl Acad Sci U S A. 1993; 90(16):7543-7.
PMID: 8356053
PMC: 47178.
DOI: 10.1073/pnas.90.16.7543.
Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes.
Dougherty W, Semler B
Microbiol Rev. 1993; 57(4):781-822.
PMID: 8302216
PMC: 372939.
DOI: 10.1128/mr.57.4.781-822.1993.
Catalytic contribution of flap-substrate hydrogen bonds in "HIV-1 protease" explored by chemical synthesis.
Baca M, Kent S
Proc Natl Acad Sci U S A. 1993; 90(24):11638-42.
PMID: 8265601
PMC: 48039.
DOI: 10.1073/pnas.90.24.11638.
In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor.
Otto M, Reid C, Garber S, Lam P, Scarnati H, Bacheler L
Antimicrob Agents Chemother. 1993; 37(12):2606-11.
PMID: 8109924
PMC: 192753.
DOI: 10.1128/AAC.37.12.2606.
High-efficiency synthesis of human alpha-endorphin and magainin in the erythrocytes of transgenic mice: a production system for therapeutic peptides.
Sharma A, White S, Dhanjal N, Huang W, Paulhiac C, Friedman E
Proc Natl Acad Sci U S A. 1994; 91(20):9337-41.
PMID: 7937766
PMC: 44807.
DOI: 10.1073/pnas.91.20.9337.
Purification and characterization of a Shiga toxin A subunit-CD4 fusion protein cytotoxic to human immunodeficiency virus-infected cells.
Al-Jaufy A, King S, Jackson M
Infect Immun. 1995; 63(8):3073-8.
PMID: 7622233
PMC: 173419.
DOI: 10.1128/iai.63.8.3073-3078.1995.
Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1.
Gottlinger H, Sodroski J, Haseltine W
Proc Natl Acad Sci U S A. 1989; 86(15):5781-5.
PMID: 2788277
PMC: 297714.
DOI: 10.1073/pnas.86.15.5781.
Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides.
Krausslich H, Ingraham R, Skoog M, Wimmer E, Pallai P, Carter C
Proc Natl Acad Sci U S A. 1989; 86(3):807-11.
PMID: 2644644
PMC: 286566.
DOI: 10.1073/pnas.86.3.807.
X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor.
Swain A, Miller M, Green J, Rich D, Schneider J, Kent S
Proc Natl Acad Sci U S A. 1990; 87(22):8805-9.
PMID: 2247451
PMC: 55048.
DOI: 10.1073/pnas.87.22.8805.
An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection.
Ashorn P, McQuade T, Thaisrivongs S, Tomasselli A, Tarpley W, Moss B
Proc Natl Acad Sci U S A. 1990; 87(19):7472-6.
PMID: 2217178
PMC: 54769.
DOI: 10.1073/pnas.87.19.7472.